Sarepta Therapeutics, INC. (SRPT) — SC 13G/A Filings
All SC 13G/A filings from Sarepta Therapeutics, INC.. Browse 6 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (6)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 13, 2024
- SC 13G/A Filing — Jun 7, 2024
-
Janus Henderson Maintains >5% Stake in Sarepta Therapeutics
— Feb 13, 2024 Risk: low
Janus Henderson Group PLC, a major investment advisor, filed an amended SC 13G/A on February 13, 2024, indicating its continued ownership of more than 5% of Sar -
Vanguard Trims Sarepta Stake to 11.2% as of Dec 29, 2023
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amendment (SC 13G/A) on February 13, 2024, updating its ownership in Sarepta Therapeutics Inc. As of Decem -
BlackRock Amends Sarepta Stake, Maintains Passive Position
— Jan 26, 2024
BlackRock Inc. filed an amended Schedule 13G/A on January 26, 2024, indicating its ownership of Sarepta Therapeutics Inc. common stock as of December 31, 2023.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX